Literature DB >> 20438703

NDRG2 is one of novel intrinsic factors for regulation of IL-10 production in human myeloid cell.

Seung-Chul Choi1, Kwang Dong Kim, Jong-Tae Kim, Sang-Seok Oh, Sun Young Yoon, Eun Young Song, Hee Gu Lee, Yong-Kyung Choe, Inpyo Choi, Jong-Seok Lim, Jae Wha Kim.   

Abstract

N-myc downstream-regulated gene 2 (NDRG2) implicated in cellular growth and differentiation was previously reported as it is specifically expressed in primary and in vitro-differentiated dendritic cells (DCs) from monocytes and CD34(+) progenitor cells. However, its function has yet to be investigated in DCs. Here, the novel NDRG2 function about modulation of cytokines in DC was observed in this study. The secretion of IL-10 was not found in the monocyte-derived DC cells with high level of NDRG2 expression, but IL-10 was abundantly secreted up to 1ng/ml in the monocyte-derived macrophages with low level of NDRG2 expression, and further confirmed that the expression of IL-10 was dramatically increased in NDRG2-silenced DCs under presence of LPS, and significantly reduced in the NDRG2-overexpressed U937 cells under stimulation of PMA. The secretion of IL-12p70 was significantly reduced in the siNDRG2 introduced DC cells. The intracellular signaling of IL-10 secretion was markedly inhibited by SB203580, inhibitor of p38 MAPK, in the LPS-activated DCs and phosphorylation of p38 MAPK was decreased in the NDRG2 introduced U937 cells under PMA-stimulation. Taken together, NDRG2 might have a pivotal role as one of intrinsic factors for the modulation of p38 MAPK phosphorylation, and subsequently involve in controlling of IL-10 production. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20438703     DOI: 10.1016/j.bbrc.2010.04.162

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Chronic psychosocial stress and citalopram modulate the expression of the glial proteins GFAP and NDRG2 in the hippocampus.

Authors:  Carolina Araya-Callís; Christoph Hiemke; Nashat Abumaria; Gabriele Flugge
Journal:  Psychopharmacology (Berl)       Date:  2012-05-18       Impact factor: 4.530

2.  NDRG2 Promotes GATA-1 Expression through Regulation of the JAK2/STAT Pathway in PMA-stimulated U937 Cells.

Authors:  Kyeongah Kang; Hyeyoun Jung; Sorim Nam; Jong-Seok Lim
Journal:  Immune Netw       Date:  2011-12-31       Impact factor: 6.303

3.  NDRG2 Sensitizes Myeloid Leukemia to Arsenic Trioxide via GSK3β-NDRG2-PP2A Complex Formation.

Authors:  Soojong Park; Hyun-Tak Han; Sang-Seok Oh; Dong Hyeok Kim; Jin-Woo Jeong; Ki Won Lee; Minju Kim; Jong Seok Lim; Yong Yeon Cho; Cheol Hwangbo; Jiyun Yoo; Kwang Dong Kim
Journal:  Cells       Date:  2019-05-22       Impact factor: 6.600

4.  The Active Constituent From Gynostemma Pentaphyllum Prevents Liver Fibrosis Through Regulation of the TGF-β1/NDRG2/MAPK Axis.

Authors:  Hui Huang; Kuifeng Wang; Qian Liu; Feihong Ji; Hu Zhou; Shanhua Fang; Jiansheng Zhu
Journal:  Front Genet       Date:  2020-11-04       Impact factor: 4.599

5.  Regulation of tumor-associated macrophage (TAM) differentiation by NDRG2 expression in breast cancer cells.

Authors:  Soyeon Lee; Aram Lee; Jihyun Lim; Jong-Seok Lim
Journal:  BMB Rep       Date:  2022-02       Impact factor: 4.778

6.  Loss of NDRG2 enhanced activation of the NF-κB pathway by PTEN and NIK phosphorylation for ATL and other cancer development.

Authors:  Tomonaga Ichikawa; Shingo Nakahata; Masahiro Fujii; Hidekatsu Iha; Kazuhiro Morishita
Journal:  Sci Rep       Date:  2015-08-13       Impact factor: 4.379

7.  Bves and NDRG4 regulate directional epicardial cell migration through autocrine extracellular matrix deposition.

Authors:  Emily C Benesh; Paul M Miller; Elise R Pfaltzgraff; Nathan E Grega-Larson; Hillary A Hager; Bong Hwan Sung; Xianghu Qu; H Scott Baldwin; Alissa M Weaver; David M Bader
Journal:  Mol Biol Cell       Date:  2013-09-18       Impact factor: 4.138

8.  Complement inhibitor factor H expressed by breast cancer cells differentiates CD14+ human monocytes into immunosuppressive macrophages.

Authors:  Karolina I Smolag; Christine M Mueni; Karin Leandersson; Karin Jirström; Catharina Hagerling; Matthias Mörgelin; Paul N Barlow; Myriam Martin; Anna M Blom
Journal:  Oncoimmunology       Date:  2020-03-06       Impact factor: 8.110

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.